Cholinergic neurones acquire adrenergic neurotransmitters when transplanted into an embryo. 1986

J N Coulombe, and M Bronner-Fraser

During development, cells become progressively restricted, until they reach their final phenotype. Differentiation was originally thought to be irreversible, but phenotypic plasticity has been observed in a variety of cell types, for example sympathetic neurones, the limb blastema and some glial cell types. A detailed description of the individual steps that lead to expression or reversal of phenotype is essential to understand the molecular events underlying cell differentiation. We examined whether ciliary neurones acquire adrenergic properties when exposed to a permissive embryonic environment. Cholinergic neurones were selectively labelled with a retrogradely transported marker and injected into chick embryos during active neural crest migration. Four to five days after injection, some of the labelled neurones were found in 'adrenergic sites' and had developed catecholamine histofluorescence. The cells had thus accumulated adrenergic neurotransmitters even after differentiation into cholinergic neurones. This result shows that neurotransmitter plasticity occurs in cholinergic neurones and suggests that the neurotransmitter phenotype can be modified by the embryonic environment.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011784 Quail Common name for two distinct groups of BIRDS in the order GALLIFORMES: the New World or American quails of the family Odontophoridae and the Old World quails in the genus COTURNIX, family Phasianidae. Quails
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D002799 Cholinergic Fibers Nerve fibers liberating acetylcholine at the synapse after an impulse. Cholinergic Fiber,Fiber, Cholinergic,Fibers, Cholinergic
D005726 Ganglia, Parasympathetic Ganglia of the parasympathetic nervous system, including the ciliary, pterygopalatine, submandibular, and otic ganglia in the cranial region and intrinsic (terminal) ganglia associated with target organs in the thorax and abdomen. Parasympathetic Ganglia,Ciliary Ganglion,Ganglion, Parasympathetic,Otic Ganglia,Pterygopalatine Ganglia,Submandibular Ganglia,Ciliary Ganglions,Ganglia, Otic,Ganglia, Pterygopalatine,Ganglia, Submandibular,Ganglias, Otic,Ganglias, Pterygopalatine,Ganglias, Submandibular,Ganglion, Ciliary,Ganglions, Ciliary,Otic Ganglias,Parasympathetic Ganglion,Pterygopalatine Ganglias,Submandibular Ganglias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

J N Coulombe, and M Bronner-Fraser
January 1986, Progress in brain research,
J N Coulombe, and M Bronner-Fraser
July 1972, Neuropharmacology,
J N Coulombe, and M Bronner-Fraser
May 1989, Medizinische Monatsschrift fur Pharmazeuten,
J N Coulombe, and M Bronner-Fraser
August 2008, European review for medical and pharmacological sciences,
J N Coulombe, and M Bronner-Fraser
June 2008, Molecular therapy : the journal of the American Society of Gene Therapy,
J N Coulombe, and M Bronner-Fraser
April 2005, Journal of medical ethics,
J N Coulombe, and M Bronner-Fraser
March 1976, Nature,
Copied contents to your clipboard!